Bioestrovet Swine (Canada)

Each 2 mL contains:

Active Ingredients

175 μg of cloprostenol (as cloprostenol sodium)

Preservatives

2% w/v benzyl alcohol

Bioestrovet Swine Indications

Bioestrovet Swine induces farrowing in sows and gilts.

Bioestrovet Swine Dosage And Administration

A dosage of 2 mL (175 μg cloprostenol) should be administered by deep intramuscular injection. The use of a multiple-dose syringe or suitable draw-off needle is recommended for the 50 mL format. If more than 10 punctures are anticipated, the use of multi-dose equipment is recommended. When using draw-off spike or needle with bore diameter larger than 21 G, discard any product remaining in the vial immediately after use.

Sows and gilts should be given Bioestrovet Swine 1 to 2 days before the expected farrowing date calculated from farm records. The average gestation length must be calculated on each farm from accurate service records so that sows may be induced to farrow at the required time. (In most situations gestation length varies between 111 and 119 days, with an average around 115 days as shown below.)

The majority of animals can be expected to respond within the period 24 ± 5 hours following injection, except in those cases where farrowing is imminent. Trials have shown that normally 95% will commence farrowing within 36 hours of treatment.

Parturition and piglet viability are normal when Bioestrovet Swine is administered 1 or 2 days before the expected farrowing date. The prediction of the precise date of farrowing is subject to error; therefore, the operator should be prepared to render extra care to piglets, if necessary.

Bioestrovet Swine Cautions

An increase in the number of nonviable piglets may result if Bioestrovet Swine is used earlier than two (2) days prior to the expected farrowing date.

WARNINGS

● No meat withdrawal period is required when used according to the label.

● Pregnant women, women of childbearing age, asthmatics and people with other respiratory tract diseases should exercise extreme caution when handling this product such as wearing waterproof gloves. Prostaglandins of the F2α type may readily be absorbed through the skin and may cause bronchospasms and/or miscarriage.

● This product should be handled carefully to avoid accidental self-injection or contact with the skin or mucous membranes of the user. In case of accidental self-injection, seek medical advice and show the package insert to the doctor. Should respiratory distress result from accidental inhalation or injection, the inhalation of a rapidly acting bronchodilator is indicated. If accidental skin contact occurs, wash immediately with water.

● Keep out of reach of children.

Adverse Reactions

Mild side effects (consisting of exaggerated nesting behavior and restlessness) may be seen occasionally.

Storage

Store between 15°C and 30°C. Protect from light by storing in its original carton. Use within 28 days timeframe of first puncture and puncture a maximum of 10 times using 21 G needle.

HOW SUPPLIED

20 mL and 50 mL multi dose vials.

Vetoquinol N.-A. Inc., 2000, ch. Georges, Lavaltrie, QC J5T 3S5

1-800-363-1700

Date of last revision: February 09, 2023

1002923 1023 A

CPN: 1234496.0